title: By Jove! What is a clinician to make of JUPITER?
authors.affiliation: Division of Cardiology, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. kaul@cshs.org
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
authors.forename: Ryan P
authors.initials: RP
authors.lastname: Morrissey
authors.forename: George A
authors.initials: GA
authors.lastname: Diamond
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D017277:Drug Approval; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009017:Morbidity / Q000639:trends; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors